Hypo-osmotic stress inhibits doxorubicin-induced apoptosis via a protein kinase A-dependent mechanism in cardiomyocytes

Clinical and Experimental Pharmacology & Physiology
Alexandra d'Anglemont de TassignyAlain Berdeaux

Abstract

1. The clinical use of doxorubicin is limited by the development of severe cardiomyopathies linked, at least in part, to an abnormal increase in the rate of apoptotic cell death. Because cell shrinkage is considered to be a crucial step at the onset of apoptosis, the aim of the present study was to investigate whether a brief hypo-osmotic stress, which leads to an increase in cell volume, could interfere with the induction of apoptosis by doxorubicin in adult cardiomyocytes. 2. Cell volume expansion results in intracellular accumulation of cAMP, so we secondarily tested whether the protective effect of hypo-osmotic stress could be related to the cAMP pathway. Accordingly, apoptosis was induced by doxorubicin (1 micromol/L) in cardiomyocytes freshly isolated from New Zealand adult rabbit hearts. 3. Exposure to doxorubicin in an iso-osmotic medium (290 mOsmol/kg H2O) induced a rapid decrease in cell volume, as well as increases in annexin V labelling and caspase-3 activity, two biological markers of apoptosis. These effects of doxorubicin were abolished by 15 min pretreatment with hypo-osmotic stress at 220 mOsmol/kgH2O (HS 220). 4. This cytoprotective effect of HS 220 was still observed when doxorubicin was added to the medium 6...Continue Reading

References

Aug 1, 1973·Cancer·E A LefrakJ A Gottlieb
Sep 1, 1996·The American Journal of Physiology·C D Bortner, J A Cidlowski
Mar 23, 2000·Cardiovascular Research·A Saraste, K Pulkki
Jul 18, 2000·American Journal of Physiology. Cell Physiology·R SouktaniP Henry
Jul 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·E MaenoY Okada
Aug 3, 2000·Neuroreport·L K ParvathenaniR Posmantur
Aug 6, 2002·Cardiovascular Research·Michelle BatthishGregory J Wilson
Aug 16, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Cynthia R L WebsterM Sawkat Anwer
Sep 13, 2002·American Journal of Physiology. Cell Physiology·Oleksandr PlatoshynJason X-J Yuan
Oct 24, 2002·Journal of Molecular and Cellular Cardiology·Kiyoshi NoboriMitsuaki Isobe
Mar 8, 2003·Journal of Molecular and Cellular Cardiology·Roberto J DiazGregory J Wilson
Jan 6, 2004·Fundamental & Clinical Pharmacology·Alexandra d'Anglemont de TassignyAlain Berdeaux

❮ Previous
Next ❯

Citations

Mar 8, 2006·Apoptosis : an International Journal on Programmed Cell Death·H-N ZhangY-Y Guan
Jan 17, 2008·Journal of Cell Science·Nola Jean ErnestHarald Sontheimer
Apr 1, 2009·The Journal of Cell Biology·Alex S FlyntJames G Patton
Jan 27, 2016·Journal of Pharmacological Sciences·Takaaki YamadaSatohiro Masuda
May 16, 2006·Trends in Pharmacological Sciences·Yong-Yuan GuanJia-Guo Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Nobuyuki TakahashiYasunobu Okada
© 2022 Meta ULC. All rights reserved